Resources from the same session
5130 - OCTOPUS - A Randomised, Multi-centre Phase II Umbrella Trial of Weekly Paclitaxel+/- Novel Agents in Platinum-Resistant Ovarian Cancer: vistusertib
Presenter: Susana Banerjee
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
2560 - BAROCCO: A randomized phase II study of weekly paclitaxel vs. cediranib-olaparib combination given with continuous or intermittent schedule in patients with recurrent platinum resistant ovarian cancer (PROC)
Presenter: Nicoletta Colombo
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
6602 - Phase 1B/2 Study of AVB500 (High Affinity Inhibitor of GAS6/AXL Path) in Combination with PAC and PLD in Platinum Resistant Recurrent Ovarian Cancer
Presenter: Bradley Monk
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
1547 - Randomized Phase 2 (RP2) Study of ATR inhibitor M6620 in Combination with Gemcitabine versus Gemcitabine alone in Platinum-Resistant High Grade Serous Ovarian Cancer (HGSOC)
Presenter: Panagiotis Konstantinopoulos
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Abstract
Slides
Webcast
Proffered Paper 1 – Gynaecological cancers - Invited Discussant LBA60 and 993O
Presenter: Domenica Lorusso
Session: Proffered Paper 1 – Gynaecological cancers
Resources:
Slides
Webcast